Advances in medical weight loss have increasingly focused on the role of hormones, metabolism, and appetite regulation rather than short-term dieting alone. One of the most notable recent developments in this area is the FDA approval of oral Wegovy, the first oral GLP-1 medication approved for chronic weight management.
At BODYWELLE, a physician-led medical wellness practice in Miami Beach, Dr. Alonso Martin is now prescribing oral Wegovy to eligible patients as part of a comprehensive medical weight loss program. This new option offers a non-injectable pathway to GLP-1 therapy while maintaining the same emphasis on medical oversight, patient safety, and long-term health.
Understanding Oral Wegovy and GLP-1 Therapy
Oral Wegovy is a prescription medication approved by the U.S. Food and Drug Administration for chronic weight management in adults who meet specific medical criteria. It belongs to a group of medications known as GLP-1 receptor agonists.
GLP-1 is a hormone produced naturally in the body after eating. It plays an important role in regulating appetite, signaling fullness, and supporting blood sugar balance. Medications that activate GLP-1 receptors help reinforce these signals, which can make it easier for patients to manage hunger and portion size over time.
GLP-1 therapies have been used in medical weight management for several years, but until recently, FDA-approved options were administered by injection. The approval of an oral formulation represents an important change in how this class of medication can be delivered.
Why an Oral GLP-1 Option Matters
For many patients, injectable medications are effective and well tolerated. For others, injections can feel like a barrier to starting or continuing treatment. An oral GLP-1 option may feel more approachable for individuals who prefer pill-based therapy or who have difficulty with injections.
Oral Wegovy expands how physicians can tailor treatment plans based on patient preference, tolerance, and medical history. While the route of administration is different, the underlying principles of care remain the same. bodfed one option within a broader treatment strategy rather than a replacement for physician-guided care.
How GLP-1 Medications Support Long-Term Weight Management
Weight management is influenced by a complex interplay of hormones, metabolism, behavior, and environment. GLP-1 medications work by supporting the body’s natural appetite-regulation systems rather than suppressing appetite through stimulants or restrictive approaches.
By enhancing satiety signals and slowing gastric emptying, GLP-1 therapy can help patients feel fuller after meals and reduce persistent hunger between meals. This can support more consistent eating patterns and make dietary changes easier to maintain over time.
At BODYWELLE, GLP-1 medications are used as part of a long-term strategy focused on metabolic health, not rapid weight changes. Medication works best when paired with physician guidance, realistic expectations, and sustainable lifestyle adjustments.
Start Your Journey to Success, Don’t Wait Any Longer!
Join our satisfied clients who’ve experienced safe, effective treatments.
Physician-Guided Care at BODYWELLE
Medical weight loss at BODYWELLE is grounded in individualized care. Dr. Martin evaluates each patient’s medical history, current medications, weight-related health concerns, and prior weight loss experiences before recommending any treatment.
Oral Wegovy is prescribed thoughtfully, with attention to dosing, potential side effects, and overall health considerations. Follow-up visits are a key part of care, allowing treatment plans to evolve based on how patients respond over time.This physician-guided approach ensures that medical weight loss remains focused on safety, education, and long-term outcomes rather than one-size-fits-all solutions. Patients interested in learning more about Dr. Martin’s background and treatment philosophy can visit the About Us page.
Experience With GLP-1 Medications
Although oral Wegovy is newly approved, BODYWELLE brings established experience with physician-supervised GLP-1 therapy, with over 127 satisfied patients treated as part of its medical weight loss program.
This experience informs how new therapies are integrated into care. Rather than emphasizing speed or volume, BODYWELLE focuses on careful patient selection, ongoing education, and long-term metabolic health. Individual responses vary, and medications are most effective when used within a structured medical framework.
Safety Considerations and Ongoing Monitoring
As with any prescription medication, oral Wegovy is not appropriate for everyone. Potential side effects, dosing considerations, and contraindications must be evaluated on an individual basis.
At BODYWELLE, patient safety is supported through comprehensive medical screening, individualized dosing decisions when appropriate, and regular follow-up. Patients receive clear guidance on what to expect during treatment, including how side effects may change over time and when to communicate concerns.
This measured approach helps ensure that medical weight loss remains aligned with long-term health rather than short-term expectations.
Who May Be a Candidate for Oral Wegovy?
Candidacy for oral Wegovy is determined during a medical consultation rather than through a checklist alone. In general, patients who may be considered include adults who:
- Have obesity or excess weight with related health concerns
- Have struggled to achieve sustained weight loss through lifestyle changes alone
- Prefer an oral medication over injectable therapies
- Are committed to physician-guided care and follow-up
Not every patient is an appropriate candidate. Certain medical conditions, medications, or health histories may affect eligibility, which is why physician evaluation is essential.
Consultations, Telemedicine, and Access to Care
BODYWELLE offers in-person consultations in Miami Beach, with virtual consultations discussed when appropriate to support continuity of care. For eligible patients, medication shipping may be available as part of a physician-guided treatment plan. This flexibility allows patients to engage in physician-guided weight management while maintaining medical oversight.
During consultation, medication access, treatment logistics, and follow-up plans are reviewed so patients have a clear understanding of their options and the structure of care within a medically supervised program.
Patients who would like to explore whether oral Wegovy may be appropriate are encouraged to schedule a consultation to discuss eligibility and treatment options with Dr. Martin.
A Measured Approach to Medical Weight Loss
The FDA approval of oral Wegovy reflects continued progress in medical weight management, but medication alone is not the solution. At BODYWELLE, oral Wegovy is offered as part of a broader, physician-directed approach focused on patient safety, education, and long-term health.
By combining evidence-based therapy with individualized care, Dr. Martin helps patients approach weight management in a way that is medically sound, sustainable, and aligned with overall well-being.